The Sea Change

Reflector

Longview

Society & Culture, Documentary

4.6 • 577 Ratings

🗓️ 30 April 2024

⏱️ 57 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Why aren’t Americans embracing the most promising medications for treating over-drinking? Become a subscriber today: reflector.show/subscribe Alcohol consumption increased more during the COVID-19 pandemic than it had at any time in the past 50 years. Even though bars were closed for weeks on end and fewer people were out on the road doing their daily commuting, Americans were drinking so much that from 2020 through 2021 there were approximately 178,000 alcohol-related deaths - which is more deaths than from all drug overdoses combined, including opioids. Yet, even as we return to 1960’s Mad Men era drinking habits - most Americans with a drinking problem never speak to their doctors about their drinking and less than 6% of them receive any form of treatment whatsoever. 12-step programs like Alcoholic Anonymous remain at the heart of a majority of American rehab programs, even though their “success rate” (which has historically been very hard to study) hovers around the single digits, while there are more effective medical options available. Why? On today’s episode, our friend Katie tells the story of her self-experimentation with the drug Naltrexone to combat her alcohol addiction and helps us grapple with why such medications are so rarely used to help problem drinkers in America. Our thanks to our guests: Addiction psychiatrist Dr. Mark Willenbring and journalist Gabrielle Glaser. Music in this episode from Cobey Bienart and Peter Lalish Email your feedback, criticisms and story suggestions to hello@reflector.show We will read all feedback and respond in a future episode. Our website: reflector.show Thank you to our sponsors. You can visit them here to learn more: FIRE GROUND.NEWS Other links: Glazer’s 2015 article in The Atlantic. Andy’s 2015 public radio story on addiction treatments. Washington University’s National Survey Study. CDC’s study on recent alcohol-related deaths. 2014 NYTimes stories on how Naltrexone and other drugs are rarely used. 2021 NYTimes story on how things have not changed. Begin your Sinclair Method Youtube Rabbit Hole here. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Clara, can you say reflector?
0:05.0	Reflector.
0:07.8	Try again, say reflector.
0:11.0	Reflector.
0:12.0	Try one more time.
0:13.0	Reflector.
0:14.2	Reflector.
0:15.7	Try one more time.
0:16.9	Rufflector.
0:17.8	Rafflector.
0:20.8	Reflector.
0:24.5	There you go. You got it.
0:26.3	Why were you doing that?
0:38.3	This is Reflector. We're going to hop into the first episode here in a second, but first, a quick word from our sponsor.
0:50.4	This episode of Reflector is brought to you by Fire, the foundation for individual rights and expression.
0:56.5	Fire is a nonpartisan advocacy organization in our country's most fervent advocate for civil liberties. I'm talking about the freedom of speech, the freedom of assembly, the freedom of
1:02.1	religion, of conscious, of due process. These are the rights that Americans most pride ourselves on,
1:08.5	and they're also the rights that we most passionately defend.
1:12.8	Fire is dedicated not only to protecting and promoting these rights, but also the culture of
1:18.1	free expression that undergirds them. Fires' legal team and their supporters defend those
1:23.7	rights for individuals across the spectrum of political views and beliefs.
1:29.3	From those who are fighting for social justice, to those fighting for religious liberty,
	...

Please login to see the full transcript.

Next episode

Disclaimer: The podcast and artwork embedded on this page are from Longview, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Longview and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.